FundedIQ
Biotechnology

Biotangents: Funding, Investors & Team (Oct 2026)

Biotangents develops next-generation molecular diagnostic assays and point-of-care devices for the detection of infectious diseases in livestock, primarily cattle

www.biotangents.co.uk LinkedIn Penicuik, United Kingdom 1-10 employees
Biotechnology Chemical Medical Device Veterinary B2B
Total raised
$4.9M
Rounds
2
Latest
Undisclosed round
Nov 2024

Biotangents has raised $4.9M across 2 funding rounds on record, the most recent an undisclosed round of $2.9M announced in Nov 2024.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Biotangents Company Profile and Key Stats

Total funding raised
$4.9M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$2.9M in Nov 2024
Employees
1-10
reported band
Headquarters
Penicuik, United Kingdom

Latest funding round on record: Nov 2024.

Biotangents Funding Rounds

Date
Round
Amount
Undisclosed round
$2.9M
Debt Financing
$2.0M

Biotangents raised $2.0M in a Debt Financing announced in May 2022.

2.5 years later, an undisclosed round of $2.9M was announced in Nov 2024.

Biotangents Founders and Leadership Team

Name
Role
Contact
Lina Gasiunaite
Founder
Locked

Contact details for the Biotangents team: 1 of 1 has an email address on file.

Start 14-day free trial →

Biotangents Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
5,368
$4.1M

Biotangents' latest round of $2.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Biotangents in Biotechnology and Penicuik

Companies Similar to Biotangents

Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…

Series C $40.4M

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…

Series C $310M

HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…

Series A $8.0M

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

Biotangents Funding FAQs

What does Biotangents do?

Biotangents develops next-generation molecular diagnostic assays and point-of-care devices for the detection of infectious diseases in livestock, primarily cattle

How much funding has Biotangents raised?

Biotangents has raised $4.9M across 2 rounds on record. The most recent is an undisclosed round of $2.9M announced in Nov 2024.

When did Biotangents last raise funding?

Biotangents' most recent funding round on record is an undisclosed round of $2.9M, announced in Nov 2024.

Who founded Biotangents?

FundedIQ lists Lina Gasiunaite (Founder) at Biotangents.

Where is Biotangents headquartered?

Biotangents is based in Penicuik, Edinburgh, United Kingdom.

How many employees does Biotangents have?

Biotangents is in the 1-10 employee band.

How does Biotangents' funding compare to other Biotechnology startups?

Biotangents' latest round of $2.9M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Biotangents Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biotangents is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.